UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway

British journal of cancer, 2014-10, Vol.111 (8), p.1552-1561

2014

Volltextzugriff (PDF)

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Annals of oncology, 2018-10, Vol.29, p.viii438-viii438

2018

Volltextzugriff (PDF)

Pluronic Enhances the Robustness and Reduces the Cell Attachment of Mammalian Cells

Molecular biotechnology, 2008-06, Vol.39 (2), p.167-177

2008

Volltextzugriff (PDF)

Outcomes of Curatively Treated De Novo Metastatic Nasopharyngeal Carcinoma: A Single Institution Experience

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e729-e729

2024

Volltextzugriff (PDF)

The Prognostic Significance of Radiation-Induced Lymphopenia in Nasopharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e730-e730

2024

Volltextzugriff (PDF)

1236TiPThe safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1273PDurvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1273P - Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30, p.v518-v518

2019

Volltextzugriff (PDF)

Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Annals of oncology, 2019-10, Vol.30, p.v518

2019

Volltextzugriff (PDF)

The WT1 antigen as a novel target for human leukemia-specific CD4+ T regulatory T cells

European journal of cancer supplements, 2008, Vol.6 (9), p.163-163

2008

Volltextzugriff (PDF)

CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analog enhance the lytic activity of leukemic cells

European journal of cancer supplements, 2008, Vol.6 (9), p.168-168

2008

Volltextzugriff (PDF)

Measurement of hydrophobic interactions of mammalian cells grown in culture

Journal of biotechnology, 2002-04, Vol.95 (1), p.39-48

2002

Volltextzugriff (PDF)

Development of an Assay for the Measurement of the Surfactant Pluronic F-68 in Mammalian Cell Culture Medium

Analytical biochemistry, 1998-08, Vol.262 (1), p.39-44

1998

Volltextzugriff (PDF)

Novel porous matrix and bioreactors for high density cultures of insulinoma cell lines: Insulin secretion and response to glucose

Journal of chemical technology and biotechnology (1986), 1998-01, Vol.71 (1), p.51-56

1998

Volltextzugriff (PDF)

Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts

Molecular and cellular biology, 2019-01, Vol.39 (2)

2019

Volltextzugriff (PDF)

Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin's Central Role in Regulating Key Pathways Related to Disease Progression

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7891

2024

Volltextzugriff (PDF)

Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer

Molecular carcinogenesis, 2020-09, Vol.59 (9), p.1041-1051

2020

Volltextzugriff (PDF)

AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1

Oncogenesis (New York, NY), 2020-08, Vol.9 (8), p.70-70, Article 70

2020

Volltextzugriff (PDF)

Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway

Cancer letters, 2021-11, Vol.520, p.374-384

2021

Volltextzugriff (PDF)

Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway

Toxicology and applied pharmacology, 2015-04, Vol.284 (2), p.217-226

2015

Volltextzugriff (PDF)

Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells

Molecular and cellular biology, 2020-04, Vol.40 (9)

2020

Volltextzugriff (PDF)

Outcome of preoperative concurrent radiation and infusional gemcitabine in locally advanced rectal cancer, a phase 2 trial

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.94-94

2022

Volltextzugriff (PDF)

Pharmacists' clinical competency towards oral mucosal diseases: Results from a mystery shopper study

Oral diseases, 2020-01, Vol.26 (1), p.89-95

2020

Volltextzugriff (PDF)

Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

BMC cancer, 2013-06, Vol.13 (1), p.289-289

2013

Volltextzugriff (PDF)

Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

BMC cancer, 2013-06, Vol.13 (1), Article 289

2013

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Breast Cancer
(8)
Animals
(6)
Biochemistry & Molecular Biology
(6)
Humans
(6)
Stem Cells
(6)
Female
(5)
Oncology
(5)
Biological And Medical Sciences
(4)
Cell Biology
(4)
Chemistry
(4)
Apoptosis
(3)
Biotechnology
(3)
Biotechnology & Applied Microbiology
(3)
Breast Neoplasms - Metabolism
(3)
Breast Neoplasms - Pathology
(3)
Cell Culture
(3)
Cell Line, Tumor
(3)
Fibroblasts
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

Pluronic Enhances the Robustness and Reduces the Cell Attachment of Mammalian Cells

Outcomes of Curatively Treated De Novo Metastatic Nasopharyngeal Carcinoma: A Single Institution Experience

The Prognostic Significance of Radiation-Induced Lymphopenia in Nasopharyngeal Carcinoma

1236TiPThe safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer

1273PDurvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

1273P - Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy

The WT1 antigen as a novel target for human leukemia-specific CD4+ T regulatory T cells

CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analog enhance the lytic activity of leukemic cells

Measurement of hydrophobic interactions of mammalian cells grown in culture

Development of an Assay for the Measurement of the Surfactant Pluronic F-68 in Mammalian Cell Culture Medium

Novel porous matrix and bioreactors for high density cultures of insulinoma cell lines: Insulin secretion and response to glucose

Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts

Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin's Central Role in Regulating Key Pathways Related to Disease Progression

Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer

AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1

Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway

Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway

Interleukin-8 Dedifferentiates Primary Human Luminal Cells to Multipotent Stem Cells

Outcome of preoperative concurrent radiation and infusional gemcitabine in locally advanced rectal cancer, a phase 2 trial

Pharmacists' clinical competency towards oral mucosal diseases: Results from a mystery shopper study

Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

Suchergebnisse filtern